ASX - By Stock
|
NEU |
Re:
Acadia
|
|
stockhead123
|
627 |
288K |
3 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
627
|
288K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
stockhead123
|
627 |
288K |
3 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
627
|
288K
|
3
|
|
ASX - By Stock
|
QPM |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
stockhead123
|
59 |
18K |
1 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
59
|
18K
|
1
|
|
ASX - By Stock
|
QPM |
Re:
Associated News
|
|
stockhead123
|
3.3K |
969K |
2 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
3.3K
|
969K
|
2
|
|
ASX - By Stock
|
QPM |
Re:
Associated News
|
|
stockhead123
|
3.3K |
969K |
23 |
29/12/23 |
29/12/23 |
ASX - By Stock
|
3.3K
|
969K
|
23
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
stockhead123
|
10K |
4.9M |
6 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
10K
|
4.9M
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
stockhead123
|
10K |
4.9M |
14 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
10K
|
4.9M
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Ann: P2 trial shows significant improvements in Phelan-McDermid
|
|
stockhead123
|
210 |
89K |
32 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
210
|
89K
|
32
|
|
ASX - By Stock
|
NEU |
Re:
Ann: P2 trial shows significant improvements in Phelan-McDermid
|
|
stockhead123
|
210 |
89K |
13 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
210
|
89K
|
13
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
stockhead123
|
315 |
158K |
30 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
315
|
158K
|
30
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
stockhead123
|
315 |
158K |
6 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
315
|
158K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
stockhead123
|
315 |
158K |
14 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
315
|
158K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
stockhead123
|
315 |
158K |
10 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
315
|
158K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
stockhead123
|
315 |
158K |
2 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
315
|
158K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
stockhead123
|
315 |
158K |
9 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
315
|
158K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
stockhead123
|
10K |
4.9M |
4 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
10K
|
4.9M
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
stockhead123
|
10K |
4.9M |
12 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
10K
|
4.9M
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
stockhead123
|
1.1K |
604K |
13 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
1.1K
|
604K
|
13
|
|
ASX - By Stock
|
NEU |
Re:
Moonsoon Briefing Thurs 20 April
|
|
stockhead123
|
94 |
41K |
6 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
94
|
41K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
stockhead123
|
10K |
4.9M |
8 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
10K
|
4.9M
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
stockhead123
|
10K |
4.9M |
14 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
10K
|
4.9M
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
stockhead123
|
10K |
4.9M |
25 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
10K
|
4.9M
|
25
|
|
ASX - By Stock
|
QPM |
Re:
Ann: QPME Moranbah Update
|
|
stockhead123
|
33 |
12K |
2 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
33
|
12K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
stockhead123
|
10K |
4.9M |
52 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
10K
|
4.9M
|
52
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
stockhead123
|
10K |
4.9M |
16 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
10K
|
4.9M
|
16
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
stockhead123
|
10K |
4.9M |
26 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
10K
|
4.9M
|
26
|
|
ASX - By Stock
|
QPM |
Re:
Associated News
|
|
stockhead123
|
3.3K |
969K |
1 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
3.3K
|
969K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
stockhead123
|
10K |
4.9M |
10 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
10K
|
4.9M
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren completes Phelan-McDermid syndrome Phase 2 trial
|
|
stockhead123
|
51 |
28K |
3 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
51
|
28K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren completes Phelan-McDermid syndrome Phase 2 trial
|
|
stockhead123
|
51 |
28K |
12 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
51
|
28K
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
stockhead123
|
10K |
4.9M |
16 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
10K
|
4.9M
|
16
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
stockhead123
|
10K |
4.9M |
14 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
10K
|
4.9M
|
14
|
|
ASX - By Stock
|
NEU |
Re:
DAYBUE BOOOOOM !!!!!!!!!!!
|
|
stockhead123
|
42 |
17K |
10 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
42
|
17K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
stockhead123
|
10K |
4.9M |
7 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
10K
|
4.9M
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
stockhead123
|
10K |
4.9M |
10 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
10K
|
4.9M
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
stockhead123
|
10K |
4.9M |
16 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
10K
|
4.9M
|
16
|
|
ASX - By Stock
|
NEU |
Re:
Ann: DAYBUE net sales US$66.9 million in Q3 2023
|
|
stockhead123
|
13 |
8.2K |
14 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
13
|
8.2K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
stockhead123
|
10K |
4.9M |
9 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
10K
|
4.9M
|
9
|
|
ASX - By Stock
|
NEU |
Re:
DAYBUE BOOOOOM !!!!!!!!!!!
|
|
stockhead123
|
42 |
17K |
16 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
42
|
17K
|
16
|
|
ASX - By Stock
|
QPM |
Re:
Associated News
|
|
stockhead123
|
3.3K |
969K |
4 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
3.3K
|
969K
|
4
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Update on Nasodine Trial and Forward Plans
|
|
stockhead123
|
29 |
9.2K |
5 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
29
|
9.2K
|
5
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Update on Nasodine Trial and Forward Plans
|
|
stockhead123
|
29 |
9.2K |
2 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
29
|
9.2K
|
2
|
|
ASX - By Stock
|
QPM |
Re:
Ann: SPP Offer Document
|
|
stockhead123
|
75 |
24K |
0 |
27/09/23 |
27/09/23 |
ASX - By Stock
|
75
|
24K
|
0
|
|
ASX - By Stock
|
QPM Energy |
Re:
QPM Presentations
|
|
stockhead123
|
26 |
8.1K |
4 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
26
|
8.1K
|
4
|
|
ASX - By Stock
|
QPM |
Re:
Ann: SPP Offer Document
|
|
stockhead123
|
75 |
24K |
1 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
75
|
24K
|
1
|
|
ASX - By Stock
|
BLU |
Re:
Ann: Galilee Basin Potential Commercial Area Decision by Qld Govt
|
|
stockhead123
|
45 |
15K |
15 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
45
|
15K
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
stockhead123
|
1.1K |
604K |
2 |
19/09/23 |
19/09/23 |
ASX - By Stock
|
1.1K
|
604K
|
2
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Phase 3 Common Cold Trial Results
|
|
stockhead123
|
90 |
35K |
1 |
13/09/23 |
13/09/23 |
ASX - By Stock
|
90
|
35K
|
1
|
|
ASX - By Stock
|
FRE |
Re:
BIG DAY TODAY HOPEFULLY
|
|
stockhead123
|
70 |
24K |
6 |
13/09/23 |
13/09/23 |
ASX - By Stock
|
70
|
24K
|
6
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Phase 3 Common Cold Trial Results
|
|
stockhead123
|
90 |
35K |
6 |
13/09/23 |
13/09/23 |
ASX - By Stock
|
90
|
35K
|
6
|
|